For the first time, ESTRO and ISRS have partnered to develop important clinical guidelines for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy (SBRT).
Just published in Radiotherapy and Oncology (The Green Journal), these guidelines represent a pioneering and collaborative effort between two globally renowned societies which will have a strong and positive impact on guiding SBRT clinical practice and improving care for patients.
Authors Prof. Alongi and Dr. Sahgal express the importance of these new guidelines:
“This joint ESTRO-ISRS document underscores the power of collaboration in addressing complex clinical topics like the re-irradiation of spinal metastases with SBRT. Through a Delphi process informed by a systematic review and meta-analysis, we have developed practical recommendations in the spinal metastatic setting for the retreatment using SBRT.
These guidelines offer clinicians much-needed clarity in a demanding clinical scenario and represent an important step toward improving patient care across institutions. Moreover, these joint guidelines are an important resource for clinicians, ensuring more standardized and high-quality care across centers and countries”.

Prof. Filippo Alongi MD
ESTRO Lead
Professor of Radiation Oncology
Chair of Advanced Radiation Oncology Dept.
IRCCS Ospedale Sacro Cuore Don Calabria
Negrar, Italy

Dr. Arjun Sahgal MD
President of ISRS
Professor of Radiation Oncology
University of Toronto
Chief of the Department of Radiation Oncology
Sunnybrook Health Sciences Centre
Toronto, Canada
All ISRS guidelines are available online.